The polycystic ovary syndrome (PCOS) is a disease affecting 6 – 12 % of women at reproductive age and characterized by abnormalities in relation to reproduction, hyperandrogenism as well as metabolic abnormalities like insulin resistance, obesity, impaired fasting glucose (IGF) and metabolic syndrome (MetS) [1, 2]. Here, IGF1 is linked to metabolic syndrome.